Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
ICU Medical, Inc.
ICUI · SEC Filings
website
13K
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that sp...
Price
178.85
Market Cap
4.47 B
Float
24.56 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about ICUI
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
ICU Medical, Inc.
ICUI · SEC Filings
24.56 M
Float
178.85
Price
4.47 B
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 5, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 6, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 7, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 19, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 6, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 7, 2025
News
TYPE
HEADLINE
FILED AT
8-K
ICU Medical Announces Third Quarter 2026 Results and Reaffirms Fiscal Year 2026 Guidance
Nov 5, 2026
8-K
ICU Medical Announces Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
Aug 6, 2026
8-K
ICU Medical, Inc. Announces Results of 2026 Annual Meeting and Governance Amendments
May 18, 2026
8-K
ICU Medical Reports First Quarter 2026 Financial Results
May 7, 2026
8-K
ICU Medical Amends Executive Severance Plan, Extending Expiration Date
Feb 20, 2026
8-K
ICU Medical Announces Q4 2025 Results and Provides FY 2026 Guidance
Feb 19, 2026
Prospectus
TYPE
HEADLINE
FILED AT
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 8, 2025
S-8
Registration
Mar 15, 2023
S-3ASR
Up to 2,500,000 Shares of
Mar 3, 2023
S-3ASR
Up to 2,500,000 Shares of
Nov 15, 2018
8-A12B/A
Registration
Feb 27, 2018
S-8
1,425,000 (2)
Jun 30, 2017
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 2, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 2, 2026
PRE 14A
Form PRE 14A - Other preliminary proxy statements
Mar 23, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 3, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 3, 2025
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 2, 2024
Ownerships
TYPE
HEADLINE
FILED AT
4
Sanzone Virginia Ruth (Reporting)
Sep 3, 2026
144
Form 144 - Report of proposed sale of securities
Sep 3, 2026
4
Bonnell Brian Michael (Reporting)
Sep 1, 2026
144
Form 144 - Report of proposed sale of securities
Sep 1, 2026
4
Bonnell Brian Michael (Reporting)
Aug 31, 2026
144
Form 144 - Report of proposed sale of securities
Aug 31, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
SD
Form SD - Specialized disclosure report
Jun 1, 2026
SD
Form SD - Specialized disclosure report
May 30, 2025
SD
Form SD - Specialized disclosure report
May 31, 2024
LETTER
Form UPLOAD - SEC-generated letter
Dec 15, 2023
CORRESP
Form CORRESP - Correspondence
Dec 14, 2023
LETTER
Form UPLOAD - SEC-generated letter
Dec 1, 2023
